Pfizer vaccine: Europe approves vaccination with Pfizer in adolescents between 12 and 15 years | Coronavirus

The European Medicines Agency (EMA) has approved the possibility of extending the use of its Pfzer / BioNTech vaccine to adolescents between 12 and 15 years of age. Expected news, as Europe hoped to be able to use it as other countries are already doing. In this way, the vaccination will be accelerated even more after verifying the (EMA) that the serum is totally “safe”. Precisely the pharmaceutical company tested its formula on 2,260 adolescents to test the formula on them. This verification gave positive and encouraging results since practically 100% of them achieved the desired immune response.In a press conference, Marco Cavaleri, head of Vaccine Strategy, confirmed this “pediatric indication” agreed today at an extraordinary committee meeting of drugs for human use (CHMP), which has concluded that the vaccine is “safe” and effective in children of this age group. However, the decision to use it will depend on each of the countries of the European Union whether to use it in this population, as explained by the head of Strategy for Vaccines and Biological Threats for Health, Marco Cavaleri. “Member States will have to decide whether and when to use it to protect a safe and effective vaccine for the younger population; It is an important step in the fight against regret, “he explained. The vaccine will follow the same administration guidelines as for adults, which means that two doses are required and must be administered at least three weeks apart.It is recommended to inject the second dose with AstraZeneca On the other hand, the European Medicines Agency assured that it maintains its recommendation to inject a second dose of the AstraZeneca vaccine to those who received a first without showing adverse effects of blood clotting because there is no evidence that the second injection increases the risk of developing thrombocytopenia compared to the first dose.In Spain, the autonomous communities give the option of choosing between this combination or the Pfizer preparation, for the second dose, and the data show that citizens clearly choose AstraZeneca to cover your vaccination. Health announces the arrival of about 4.6 million vaccines next week Health announces the arrival of about 4.6 million vaccines next week From the Ministry of Health it has also been reported that about 4.6 million vaccines will be received against Covid-19 next week. In this way, the vaccination rate can be increased. In this sense, the data show that more than 25.7 million doses have been administered to date. A total of 17.5 million people have at least one dose, which is almost 40% of the population; 8.6 million people already have the full guideline, which represents about 20% of the total.